MDS clinical diagnostic criteria for Parkinson’s disease

Cited by (1,020)

Items 501–600 of 1,020

  1. Wearable sensor-based quantitative gait analysis in Parkinson’s disease patients with different motor subtypes
    Weishan Zhang, Yun Ling, Zhonglue Chen, Kang Ren, Shengdi Chen, Pei Huang, Yuyan Tan · 2024 · npj Digital Medicine
  2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson’s and Alzheimer’s Diseases and Relation to Cognition
    Jonáš Kunst, Radek Mareček, Patrícia Klobušiaková, Zuzana Balážová, Ľubomíra Anderková, Nela Elfmarková, Irena Rektorová · 2018 · Brain Topography
  3. Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson's Disease
    Lirong Jin, Jian Wang, Changpeng Wang, Danlan Lian, Ying Zhou, Yong Zhang, Minzhi Lv, Yuanfang Li, Zhen Huang, Xiaoqin Cheng et al. · 2019 · Frontiers in Neurology
  4. Adaptive sparse learning using multi-template for neurodegenerative disease diagnosis
    Baiying Lei, Yujia Zhao, Zhongwei Huang, Xiaoke Hao, Feng Zhou, Ahmed Elazab, Jing Qin, Haijun Lei · 2020 · Medical Image Analysis
  5. A Stage-Based Approach to Therapy in Parkinson’s Disease
    Claudia Carrarini, Mirella Russo, Fedele Dono, Martina Di Pietro, Marianna Gabriella Rispoli, Vincenzo Di Stefano, Laura Ferri, Filomena Barbone, Michela Vitale, Astrid Thomas et al. · 2019 · Biomolecules
  6. Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease
    Irene Rosas, Carmen Martínez, Jordi Clarimón, Alberto Lleó, Ignacio Illán‐Gala, Oriol Dols‐Icardo, Barbara Borroni, Maria Rosário Almeida, Julie van der Zee, Christine Van Broeckhoven et al. · 2019 · Neurobiology of Aging
  7. Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson’s Disease Severity
    Wanlin Yang, Zihan Chang, Rongfang Que, Guomei Weng, Bin Deng, Ting Wang, Zifeng Huang, Fen Xie, Xiaobo Wei, Qin Yang et al. · 2020 · Frontiers in Aging Neuroscience
  8. Activating transcription factor-4 promotes neuronal death induced by Parkinson’s disease neurotoxins and α-synuclein aggregates
    Matthew D. Demmings, Elizabeth C. Tennyson, Gillian N. Petroff, Heather E. Tarnowski-Garner, Sean P. Cregan · 2020 · Cell Death and Differentiation
  9. Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
    Giovanni Bellomo, Antonio Indaco, Davide Chiasserini, Emanuela Maderna, Federico Paolini Paoletti, Lorenzo Gaetani, Silvia Paciotti, Maya Petricciuolo, Fabrizio Tagliavini, Giorgio Giaccone et al. · 2021 · Frontiers in Neuroscience
  10. Quantitative Gait Analysis Using a Pose-Estimation Algorithm with a Single 2D-Video of Parkinson’s Disease Patients
    Jung Hwan Shin, Ri Yu, Jed Noel Ong, Chan Young Lee, Seung Ho Jeon, Hwanpil Park, Han-Joon Kim, Jehee Lee, Beomseok Jeon · 2021 · Journal of Parkinson s Disease
  11. Computer vision quantification of whole-body Parkinsonian bradykinesia using a large multi-site population
    Gareth Morinan, Yuriy Dushin, Grzegorz Sarapata, Samuel Rupprechter, Yuwei Peng, Christine Girges, Maricel Salazar, Catherine Milabo, Krista G. Sibley, Thomas Foltynie et al. · 2023 · npj Parkinson s Disease
  12. Transcriptomic profiling of Parkinson's disease brains reveals disease stage specific gene expression changes
    Chiara Cappelletti, Sandra Pilar Henriksen, Hanneke Geut, Annemieke J.M. Rozemüller, Wilma D. J. van de Berg, Lasse Pihlstrøm, Mathias Toft · 2023 · Acta Neuropathologica
  13. Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease
    Daisuke Taniguchi, Taku Hatano, Koji Kamagata, Ayami Okuzumi, Yutaka Oji, Akio Mori, Masaaki Hori, Shigeki Aoki, Nobutaka Hattori · 2018 · Movement Disorders
  14. Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson’s disease: recommendations from an expert panel
    Rajesh Pahwa, Stuart Isaacson, Diego R. Torres‐Russotto, Fatta B. Nahab, Peter Matthew Lynch, Katya E. Kotschet · 2018 · Expert Review of Neurotherapeutics
  15. The Classification of Minor Gait Alterations Using Wearable Sensors and Deep Learning
    Alexander P. Turner, Stephen Clive Hayes · 2019 · IEEE Transactions on Biomedical Engineering
  16. Essential Tremor and Parkinson’s Disease: Exploring the Relationship
    Arjun Tarakad, Joseph J. Jankovic · 2018 · Europe PMC (PubMed Central)
  17. Dysregulated Long Non-coding RNAs in Parkinson’s Disease Contribute to the Apoptosis of Human Neuroblastoma Cells
    Yun Fan, Jingyi Li, Qingmei Yang, Chengwu Gong, Hongling Gao, Zhijuan Mao, Xiao Yuan, Suiqiang Zhu, Zheng Xue · 2019 · Frontiers in Neuroscience
  18. “Smelling and Tasting” Parkinson's Disease: Using Senses to Improve the Knowledge of the Disease
    Valentina Oppo, Marta Melis, Melania Melis, Iole Tomassini Barbarossa, Giovanni Cossu · 2020 · Frontiers in Aging Neuroscience
  19. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson’s disease
    Shishuai Xie, Wanxiang Niu, Feng Xu, Yuping Wang, Shanshan Hu, Chaoshi Niu · 2020 · International Journal of Neuroscience
  20. Screening for prodromal Parkinson's disease in the general community: a sleep-based approach
    Ronald B. Postuma, Amélie Pelletier, Daniela Berg, Jean‐François Gagnon, Frédérique Escudier, Jacques Yves Montplaisir · 2016 · Sleep Medicine
  21. Four-week trunk-specific exercise program decreases forward trunk flexion in Parkinson's disease: A single-blinded, randomized controlled trial
    Marialuisa Gandolfi, Michèle Tinazzi, Francesca Magrinelli, Giulia Busselli, Eleonora Kirilova Dimitrova, Niccolò Polo, Paolo Manganotti, Alfonso A. Fasano, Nicola Smania, Christian Geroin · 2019 · Parkinsonism & Related Disorders
  22. Brain Entropy During Aging Through a Free Energy Principle Approach
    Filippo Cieri, Xiaowei Zhuang, Jessica Caldwell, Dietmar Cordes · 2021 · Frontiers in Human Neuroscience
  23. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson’s disease
    Qihua Chen, Na Deng, Ke Lu, Qiao Liao, Xiaoyan Long, Deming Gou, Fangfang Bi, Jinxia Zhou · 2021 · Scientific Reports
  24. Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning
    Yu Shan Zhao, Ping Wu, Jianjun Wu, Matthias Brendel, Jiaying Lu, Jingjie Ge, Chunmeng Tang, Jimin Hong, Qian Xu, Fengtao Liu et al. · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
  25. Multifunctional role of natural products for the treatment of Parkinson’s disease: At a glance
    Md. Mominur Rahman, Xiaoyan Wang, Md. Rezaul Islam, Shopnil Akash, Fatema Akter Supti, Mohona Islam Mitu, Md. Harun-Or-Rashid, Most. Nazmin Aktar, Most. Sumaiya Khatun Kali, Farhana Israt Jahan et al. · 2022 · Frontiers in Pharmacology
  26. Defining Parkinson’s Disease: Past and Future
    Kristína Kulcsárová, Matěj Škorvánek, Ronald B. Postuma, Daniela Berg · 2024 · Journal of Parkinson s Disease
  27. A systematic review and meta-analysis of the prevalence of Parkinson’s disease in lower to upper-middle-income countries
    Gabriela Magalhães Pereira, Daniel Teixeira dos Santos, Nayron Medeiros Soares, Gabriel Alves Marconi, Deise C. Friedrich, Paula Saffie Awad, Bruno Lopes Santos‐Lobato, Pedro Renato de Paula Brandão, Alastair John Noyce, Connie Marras et al. · 2024 · npj Parkinson s Disease
  28. Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
    Masaru Tanaka · 2025 · Cells
  29. Loss of Substantia Nigra Hyperintensity at 3.0-T MR Imaging in Idiopathic REM Sleep Behavior Disorder: Comparison with 123I-FP-CIT SPECT
    Yun Jung Bae, Jong‐Min Kim, Kyeong Joon Kim, Eunhee Kim, Hyun Soo Park, Seo Young Kang, In‐Young Yoon, Jee‐Young Lee, Beomseok Jeon, Sang Eun Kim · 2017 · Radiology
  30. Metabolomics‐based identification of metabolic alterations in PARK2
    Ayami Okuzumi, Taku Hatano, Shin‐Ichi Ueno, Takashi Ogawa, Shinji Saiki, Akio Mori, Takahiro Koinuma, Yutaka Oji, Kei‐ichi Ishikawa, Motoki Fujimaki et al. · 2019 · Annals of Clinical and Translational Neurology
  31. Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of Medication
    Igor Straka, Michal Minár, Matěj Škorvánek, Milan Grofik, Katarína Danterová, Ján Benetin, Egon Kurča, Andrea Gažová, Veronika Boleková, Kathryn A Wyman‐Chick et al. · 2019 · Frontiers in Neurology
  32. Disruption of posterior brain functional connectivity and its relation to cognitive impairment in idiopathic REM sleep behavior disorder
    Anna Campabadal, Alexandra Abós, Bàrbara Segura, Mónica Serradell, Carme Uribe, Hugo César Baggio, Carles Gaig, Joan Santamaría, Yaroslau Compta, Núria Bargalló et al. · 2019 · NeuroImage Clinical
  33. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series
    Hanneke Geut, Dagmar H. Hepp, Elisabeth M. J. Foncke, Henk W. Berendse, Annemieke J.M. Rozemüller, Inge Huitinga, Wilma D. J. van de Berg · 2020 · Acta Neuropathologica Communications
  34. Machine learning for automated EEG-based biomarkers of cognitive impairment during Deep Brain Stimulation screening in patients with Parkinson’s Disease
    Victor Jacobus Geraedts, Milan Koch, Maria Fiorella Contarino, Huub A. M. Middelkoop, Hao Wang, Jacobus Johannes van Hilten, Thomas Bäck, Martijn Rudolf Tannemaat · 2021 · Clinical Neurophysiology
  35. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
    Ya-Shuo Feng, Zixuan Tan, Linyu Wu, Fang Dong, Feng Zhang · 2021 · Biomedicine & Pharmacotherapy
  36. Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
    Dariusz Koziorowski, Monika Figura, Łukasz Milanowski, Stanisław Szlufik, Piotr Alster, Natalia Madetko‐Alster, Andrzej Friedman · 2021 · Cells
  37. New concepts in the pathogenesis and presentation of Parkinson’s disease
    Anna Sauerbier, Mubasher A. Qamar, Thadshani Rajah, К. Ray Chaudhuri · 2016 · Clinical Medicine
  38. Multivariate radiomics models based on 18F-FDG hybrid PET/MRI for distinguishing between Parkinson’s disease and multiple system atrophy
    Xuehan Hu, Xun Sun, Fan Hu, Fang Liu, Weiwei Ruan, Tingfan Wu, Rui Fang An, Xiaoli Lan · 2021 · European Journal of Nuclear Medicine and Molecular Imaging
  39. The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play
    Sonia Azeggagh, Daniel C. Berwick · 2021 · British Journal of Pharmacology
  40. Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
    Hiroaki Sekiya, Asato Tsuji, Yuki Hashimoto, Mariko Takata, Shunsuke Koga, Katsuya Nishida, Naonobu Futamura, Michi Kawamoto, Nobuo Kohara, Dennis W. Dickson et al. · 2022 · Acta Neuropathologica Communications
  41. Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders
    Johanna Nilsson, Julius Constantinescu, Bengt Nellgård, Protik Jakobsson, Wagner Scheeren Brum, Johan Gobom, Lars Forsgren, Keti Dalla, Radu Constantinescu, Henrik Zetterberg et al. · 2022 · Movement Disorders
  42. Care access and utilization among medicare beneficiaries living with Parkinson’s disease
    Caroline F. Pearson, Alex Hartzman, Dianne Munevar, Megan P. Feeney, Rachel Dolhun, Veronica Todaro, Sheera Rosenfeld, Allison Wright Willis, James C. Beck · 2023 · npj Parkinson s Disease
  43. A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis
    Ruth Chia, Ruin Moaddel, Justin Y. Kwan, Memoona Rasheed, Paola Ruffo, Natalie Landeck, Paolo Reho, Rosario Vasta, Andrea Calvo, Cristina Moglia et al. · 2025 · Nature Medicine
  44. Abolishing the 1‐year rule: How much evidence will be enough?
    R. Postuma, D. Berg, M. Stern, W. Poewe, C. Olanow, W. Oertel, K. Marek, I. Litvan, Anthony E. Lang, G. Halliday et al. · 2016 · Movement Disorders
  45. The New Diagnostic Criteria for Parkinson's Disease
    Ronald B. Postuma, Daniela Berg · 2017 · International review of neurobiology
  46. Dynamic Functional Connectivity and Symptoms of Parkinson’s Disease: A Resting-State fMRI Study
    Gwenda Engels, Annemarie M. M. Vlaar, Brónagh McCoy, Erik Scherder, Linda Douw · 2018 · Frontiers in Aging Neuroscience
  47. Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
    Alessia Indrieri, Rocco Pizzarelli, Brunella Franco, Elvira De Leonibus · 2020 · Frontiers in Neuroscience
  48. An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease
    Toshiki Uchihara · 2016 · Neuropathology
  49. Suicide in Parkinson’s disease
    Melissa D. Shepard, Kate M. Perepezko, Martijn P. G. Broen, Jared T. Hinkle, Ankur Butala, Kelly A. Mills, Julie Nanavati, Nicole Mercado Fischer, Paul Sasha Nestadt, Gregory M. Pontone · 2019 · Journal of Neurology Neurosurgery & Psychiatry
  50. Parkinson’s Disease Classification and Clinical Score Regression via United Embedding and Sparse Learning From Longitudinal Data
    Zhongwei Huang, Haijun Lei, Guoliang Chen, Alejandro Federico Frangi, Yanwu Xu, Ahmed Elazab, Jing Qin, Baiying Lei · 2021 · IEEE Transactions on Neural Networks and Learning Systems
  51. Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson’s Disease
    Philipp Portz, Michael K. Lee · 2021 · Cells
  52. Specific immune status in Parkinson’s disease at different ages of onset
    Jun Tian, Shaobing Dai, Sisi Jiang, Wenyi Yang, Yiqun Yan, Zhihao Lin, Jia‐Xian Dong, Yi Liu, Ran Zheng, Ying Chen et al. · 2022 · npj Parkinson s Disease
  53. Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression
    Shady Rahayel, Christina Tremblay, Andrew Vo, Ying Qiu Zheng, Stéphane Lehéricy, Isabelle Arnulf, Marie Vidailhet, Jean‐Christophe Corvol, ICEBERG Study Group, Marie Vidailhet et al. · 2022 · Brain
  54. The role of nutrition on Parkinson’s disease: a systematic review
    Vittorio Emanuele Bianchi, Laura Rizzi, Fahad A. Somaa · 2022 · Nutritional Neuroscience
  55. Parkinson's Disease: Risk Factor Modification and Prevention
    Suraj M. Rajan, Bonnie M. Kaas · 2022 · Seminars in Neurology
  56. Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson’s disease
    Hiroaki Sekiya, Lukas Franke, Yuki Hashimoto, Mariko Takata, Katsuya Nishida, Naonobu Futamura, Kazuko Hasegawa, Hisatomo Kowa, Owen A. Ross, Pamela J. McLean et al. · 2025 · Acta Neuropathologica
  57. Treatment of psychotic symptoms in patients with Parkinson disease
    Jack J. Chen · 2017 · Mental Health Clinician
  58. Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study
    Micol Avenali, Marco Toffoli, Stephen Mullin, Alisdair McNeill, Derralynn A. Hughes, Atul B Mehta, Fabio Blandini, Anthony H.V. Schapira · 2019 · Journal of Neurology Neurosurgery & Psychiatry
  59. Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson’s disease
    Congcong Sun, Zhenxiang Zhao, Wenfei Yu, Mingshu Mo, Chengyuan Song, Youfeng Si, Yiming Liu · 2019 · Annals of Translational Medicine
  60. Re‐emergent Tremor in Parkinson's Disease: The Role of the Motor Cortex
    Giorgio Leodori, Daniele Belvisi, Maria Ilenia De Bartolo, Andrea Fabbrini, Matteo Costanzo, Felipe Vial U, Antonella Conte, Mark Hallett, Alfredo Berardelli · 2020 · Movement Disorders
  61. Chronic Pain Treatment Strategies in Parkinson’s Disease
    Amber N. Edinoff, Niroshan Sathivadivel, Timothy McBride, Allyson Parker, Chikezie N. Okeagu, Alan D. Kaye, Adam Marc Kaye, Jessica S. Kaye, Rachel J. Kaye, Meeta M. Sheth et al. · 2020 · Neurology International
  62. Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease
    Ravanidis, Stylianos, Bougea, Anastasia, Papagiannakis, Nikolaos, Maniati, Matina, Koros, Christos, Simitsi, Athina‐Maria, Bozi, Maria, Pachi, Ioanna, Stamelou, Maria, Paraskevas, George P. et al. · 2020 · Movement Disorders
  63. The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism
    Lydia Chougar, Nadya Pyatigorskaya, Bertrand Degos, David Grabli, Stéphane Lehéricy · 2020 · Frontiers in Neurology
  64. A Prodromal Brain‐Clinical Pattern of Cognition in Synucleinopathies
    Shady Rahayel, Ronald B. Postuma, Jacques Yves Montplaisir, Bratislav Mišić, Christina Tremblay, Andrew Vo, Simon J.G. Lewis, Elie Matar, Kaylena A. Ehgoetz Martens, Frédéric Blanc et al. · 2020 · Annals of Neurology
  65. Gait variability is sensitive to detect Parkinson’s disease patients at high fall risk
    Lin Ma, Taomian Mi, Qian Jia, Chao Han, Jagadish Kumar Chhetri, Piu Chan · 2020 · International Journal of Neuroscience
  66. Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy
    Yasuo Miki, Eiki Tsushima, Sandrine C. Foti, Kate M Strand, Yasmine T. Asi, Adam Kenji Yamamoto, Conceição Bettencourt, Marcos Castello Barbosa de Oliveira, Eduardo De Pablo‐Fernández, Zane Jaunmuktane et al. · 2021 · Brain
  67. Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies
    Maitane Martinez-Eguiluz, Olatz Arbelaitz, Ibai Gurrutxaga, Javier Muguerza, Iñigo Perona, Ane Murueta‐Goyena, Marian Acera, Rocío Del Pino, Beatriz Tijero, Juan Carlos Gómez‐Esteban et al. · 2022 · Neural Computing and Applications
  68. Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials
    Jimin Ren, Richard B. Dewey, Austin Rynders, Jacob Evan, Jeremy Evan, Shelia Ligozio, Karen S. Ho, Peter V. Sguigna, Robert Glanzman, Michael T. Hotchkin et al. · 2023 · Journal of Nanobiotechnology
  69. Arterial spin labelling detects posterior cortical hypoperfusion in non-demented patients with Parkinson’s disease
    Zoe Joanna Syrimi, Ľubomír Vojtíšek, Ilona Eliasova, Jana Víšková, Alena Svátková, Jiri Vanicek, Irena Rektorová · 2017 · Journal of Neural Transmission
  70. The Gut and Nonmotor Symptoms in Parkinson's Disease
    Lisa Klingelhoefer, Heinz Reichmann · 2017 · International review of neurobiology
  71. Differential insular cortex subregional vulnerability to α‐synuclein pathology in Parkinson's disease and dementia with Lewy bodies
    Yasmine Y. Fathy, Allert J. Jonker, Ellen Oudejans, F. J. J. de Jong, Anne‐Marie van Dam, Annemieke J.M. Rozemüller, Wilma D. J. van de Berg · 2018 · Neuropathology and Applied Neurobiology
  72. A Case of Parkinson’s Disease with No Lewy Body Pathology due to a Homozygous Exon Deletion in Parkin
    Krisztina Kunszt Johansen, SVERRE HELGE TORP, Matthew James Farrer, Emil Karl Gustavsson, Jan Olav Aasly · 2018 · Case Reports in Neurological Medicine
  73. Convolutional neural network-based segmentation can help in assessing the substantia nigra in neuromelanin MRI
    Alice Le Berre, Koji Kamagata, Yujiro Otsuka, Christina Andica, Taku Hatano, Laetitia Saccenti, Takashi Ogawa, Haruka Takeshige‐Amano, Akihiko Wada, Michimasa Suzuki et al. · 2019 · Neuroradiology
  74. Cingulate cortex in Parkinson's disease
    Brent Alan Vogt · 2019 · Handbook of clinical neurology
  75. Update on the Management of Parkinson’s Disease for General Neurologists
    Zvezdan Pirtošek, Ovidiu Alexandru Bajenaru, Norbert Kovács, Ivan Gospodinov Milanov, Maja Relja, Matěj Škorvánek · 2020 · Parkinson s Disease
  76. Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis
    Cristiano Carlomagno, Paolo Innocente Banfi, Alice Gualerzi, Silvia Picciolini, Eleonora Volpato, Mario Meloni, Agata Lax, Eleonora Colombo, Nicola Ticozzi, Federico Verde et al. · 2020 · Scientific Reports
  77. Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases
    Giovanni Palermo, Sonia Mazzucchi, Alessandra Della Vecchia, Gabriele Siciliano, Ubaldo Bonuccelli, Carole Azuar, Roberto Ceravolo, Simone Lista, Harald Juergen Hampel, Filippo Baldacci · 2020 · Molecular Neurobiology
  78. Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson disease
    Alessandra Fanciulli, Nicole Campese, Georg Goebel, Jean Pierre Ndayisaba, Sabine Eschlboeck, Christine Kaindlstorfer, Cecilia Raccagni, Roberta Granata, Ubaldo Bonuccelli, Roberto Ceravolo et al. · 2020 · Neurology
  79. Genotype–Phenotype Relations for the Atypical Parkinsonism Genes: MDSGene Systematic Review
    Christina Wittke, Sonja Petkovic, Valerija Dobričić, Susen Schaake, MDS‐endorsed PSP Study Group, Gesine Respondek, Anne Weißbach, Harutyun Madoev, Joanne Trinh, Eva‐Juliane Vollstedt et al. · 2021 · Movement Disorders
  80. Prediabetes, type 2 diabetes mellitus and risk of Parkinson’s disease: A population-based cohort study
    Almudena Sánchez‐Gómez, Yesika Díaz, Talita Duarte‐Salles, Yaroslau Compta, Marı́a José Martı́ · 2021 · Parkinsonism & Related Disorders
  81. Oral, Nasal, and Gut Microbiota in Parkinson’s Disease
    Li, Zhuo, Lu, Gang, Luo, Enli, Wu, Bin, Li, Zhe, Guo, Jianwen, Xia, Zhangyong, Zheng, Chunye, Su, Qiaozhen, Zeng, Yan et al. · 2022 · Neuroscience
  82. Validation of a Device for the Ambulatory Monitoring of Sleep Patterns: A Pilot Study on Parkinson's Disease
    Carlos Javier Madrid-Navarro, Francisco Javier Puertas, Francisco Escamilla Sevilla, Manuel Campos, Fernando Ruiz Abellán, Maria Angeles Rol, Juan Antonio Madrid · 2019 · Frontiers in Neurology
  83. Multimodal phenotypic axes of Parkinson’s disease
    Ross D. Markello, Golia Shafiei, Christina Tremblay, Ronald B. Postuma, Alain Dagher, Bratislav Mišić · 2021 · npj Parkinson s Disease
  84. Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease
    Nicolaas Ida Bohnen, Prabesh Kanel, Robert A. Koeppe, Carlos A. Sánchez-Catasús, Kirk A. Frey, Peter J. H. Scott, Gregory M. Constantine, Roger L. Albin, Martijn L.T.M. Müller · 2021 · Brain Communications
  85. Use of machine learning method on automatic classification of motor subtype of Parkinson's disease based on multilevel indices of rs-fMRI
    Huize Pang, Ziyang Yu, Hongmei Yu, Jibin Cao, YingMei Li, Miaoran Guo, Chenghao Cao, Guoguang Fan · 2021 · Parkinsonism & Related Disorders
  86. Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms
    Cecilia Peralta, Antonio P. Strafella, Thilo van Eimeren, Roberto Ceravolo, Klaus Seppi, Valtteri Kaasinen, Julieta Arena, Stéphane Lehéricy, the International Parkinson Movement Disorders Society‐Neuroimaging Study Group · 2021 · Movement Disorders Clinical Practice
  87. Cardiac Changes in Parkinson’s Disease: Lessons from Clinical and Experimental Evidence
    Lorena Cuenca‐Bermejo, Pilar Almela, Javier Navarro‐Zaragoza, Emiliano Fernández‐Villalba, Ana María González Cuello, M. Luisa Laorden, María Trinidad Herrero · 2021 · International Journal of Molecular Sciences
  88. Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker
    Marie‐Therese Mackmull, Luise Nagel, Fabian Sesterhenn, Jan Muntel, Jan Großbach, Patrick Stalder, Roland Bruderer, Lukas Reiter, Wilma D. J. van de Berg, Natalie de Souza et al. · 2022 · Nature Structural & Molecular Biology
  89. Neurodegeneration cell per cell
    Sriram Balusu, Roman Praschberger, Elsa Lauwers, Bart De Strooper, Patrik Verstreken · 2023 · Neuron
  90. The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons
    Jace Jones-Tabah, Kathy He, Nathan C. Karpilovsky, Konstantin A. Senkevich, Ghislaine Deyab, Isabella Pietrantonio, Thomas Goiran, Yuting Cousineau, Daria Nikanorova, Taylor Goldsmith et al. · 2024 · Molecular Neurodegeneration
  91. Mild cognitive impairment in Parkinson’s disease
    Saül Martínez‐Horta, Jaime Kulisevsky · 2019 · Journal of Neural Transmission
  92. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson’s disease
    Nancy J. Butcher, Connie Marras, Margarita Pondal, Pablo Rusjan, Erik Boot, Leigh Christopher, Gabriela M. Repetto, Rosemarie Fritsch M, Eva W.C. Chow, Mario Masellis et al. · 2017 · Brain
  93. Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort
    B. Peyronnet, Gregory W. Vurture, Jose‐Alberto Palma, Dominique R. Malacarne, Andrew Feigin, Rachael D. Sussman, Milton Cesar Biagioni, Ricardo Palmerola, Rebecca Gilbert, Nirit Rosenblum et al. · 2018 · Parkinsonism & Related Disorders
  94. Medical Cannabis for Older Patients—Treatment Protocol and Initial Results
    Ran Abuhasira, Addie Ron, Inbal Sikorin, Victor Novack · 2019 · Journal of Clinical Medicine
  95. Bradykinesia in Alzheimer’s disease and its neurophysiological substrates
    Matteo Bologna, Andrea Guerra, Donato Colella, Ettore Cioffi, Giulia Paparella, Antonella Di Vita, Fabrizia D’Antonio, Alessandro Trebbastoni, Alfredo Berardelli · 2020 · Clinical Neurophysiology
  96. Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
    Srinivasa Reddy Bonam, Christine Tranchant, Sylviane Muller · 2021 · Cells
  97. Peripheral insulin and amylin levels in Parkinson's disease
    Sánchez-Gómez, Almudena, Alcarraz-Vizán, Gema, Fernández, Manel, Fernández-Santiago, Rubén, Ezquerra, Mario, Cámara, Ana, Serrano, Mònica, Novials, Anna, Muñoz, Esteban, Valldeoriola, Francesc et al. · 2020 · Parkinsonism & Related Disorders
  98. New hopes for disease modification in Parkinson's Disease
    Werner H Poewe, Klaus Seppi, Kathrin Marini, Philipp Mahlknecht · 2020 · Neuropharmacology
  99. GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson’s disease: a two-cohort case-control study
    Hong-xu Pan, Yuwen Zhao, Junpu Mei, Zhenghuan Fang, Yige Wang, Xun Clare Zhou, Yangjie Zhou, Rui Zhang, Kailin Zhang, Jiang Li et al. · 2020 · Translational Neurodegeneration
  100. Alterations in Degree Centrality and Functional Connectivity in Parkinson’s Disease Patients With Freezing of Gait: A Resting-State Functional Magnetic Resonance Imaging Study
    Miaoran Guo, Yan Ren, Hongmei Yu, Huaguang Yang, Chenghao Cao, Yingmei Li, Guoguang Fan · 2020 · Frontiers in Neuroscience